HK1109803A1 - Amnion-derived cell compositions, methods of making and uses thereof - Google Patents
Amnion-derived cell compositions, methods of making and uses thereofInfo
- Publication number
- HK1109803A1 HK1109803A1 HK08103796.2A HK08103796A HK1109803A1 HK 1109803 A1 HK1109803 A1 HK 1109803A1 HK 08103796 A HK08103796 A HK 08103796A HK 1109803 A1 HK1109803 A1 HK 1109803A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- amnion
- making
- methods
- derived cell
- cell compositions
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66694905P | 2005-03-31 | 2005-03-31 | |
US69925705P | 2005-07-14 | 2005-07-14 | |
US74206705P | 2005-12-02 | 2005-12-02 | |
US33384906A | 2006-01-18 | 2006-01-18 | |
PCT/US2006/011392 WO2006105152A2 (en) | 2005-03-31 | 2006-03-29 | Amnion-derived cell compositions, methods of making and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1109803A1 true HK1109803A1 (en) | 2008-06-20 |
Family
ID=37054053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08103796.2A HK1109803A1 (en) | 2005-03-31 | 2008-04-03 | Amnion-derived cell compositions, methods of making and uses thereof |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1864132B1 (zh) |
JP (1) | JP5017253B2 (zh) |
CN (12) | CN103361303B (zh) |
CA (1) | CA2602684C (zh) |
DK (1) | DK1864132T3 (zh) |
ES (1) | ES2387402T3 (zh) |
HK (1) | HK1109803A1 (zh) |
WO (1) | WO2006105152A2 (zh) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
CA2530533C (en) | 2003-06-27 | 2015-02-10 | Ethicon, Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US9175261B2 (en) | 2005-12-16 | 2015-11-03 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
SG170761A1 (en) | 2006-03-23 | 2011-05-30 | Pluristem Ltd | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
EP2035093A4 (en) * | 2006-06-14 | 2010-02-17 | Stemnion Inc | METHODS FOR TREATING SPINAL CORD INJURY AND MINIMIZING THE SCALING SCALE |
US8475788B2 (en) * | 2006-06-14 | 2013-07-02 | Stemnion, Inc. | Methods of treating spinal cord injury and minimizing scarring |
JP5670053B2 (ja) * | 2006-11-13 | 2015-02-18 | エシコン・インコーポレイテッドEthicon, Incorporated | マイクロキャリアを使用した、産褥由来の細胞の生体外での拡大 |
GB2444232A (en) * | 2006-11-30 | 2008-06-04 | Ethicon Inc | Wound dressing compositions comprising cell lysates |
WO2009008928A2 (en) | 2007-04-13 | 2009-01-15 | Stemnion, Inc. | Methods for treating nervous system injury and disease |
WO2009014668A2 (en) * | 2007-07-24 | 2009-01-29 | Stemnion, Inc. | Methods for promoting hair growth |
RU2473685C2 (ru) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
CA2696877A1 (en) * | 2007-08-22 | 2009-02-26 | Stemnion, Inc. | Novel cellular factor-containing solution compositions |
WO2009037690A1 (en) | 2007-09-19 | 2009-03-26 | Pluristem Ltd. | Adherent cells from adipose or placenta tissues and use thereof in therapy |
RU2473684C2 (ru) | 2007-11-27 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
RU2562154C2 (ru) * | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
WO2010071864A1 (en) | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Treatment of lung and pulmonary diseases and disorders |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
BRPI1013409A2 (pt) | 2009-03-26 | 2018-01-16 | Advanced Tech And Regenerative Medicine Llc | células de tecido de cordão umbilical humano como terapia para doença de alzheimer |
KR102058901B1 (ko) | 2009-07-20 | 2019-12-24 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
EP2569419B1 (en) | 2010-05-12 | 2019-03-20 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
WO2012000180A1 (zh) * | 2010-06-30 | 2012-01-05 | Chen Jinxi | 一种皮肤组织细胞聚合物的制备方法及其用途 |
US20130123647A1 (en) | 2011-05-03 | 2013-05-16 | The Research Foundation Of State University Of New York | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
KR102203056B1 (ko) | 2011-12-22 | 2021-01-14 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화 |
BR112014015424A2 (pt) | 2011-12-23 | 2018-05-22 | Depuy Synthes Products Llc | detecção de células derivadas de tecido do cordão umbilical humano |
AU2014240603B2 (en) | 2013-03-14 | 2017-11-09 | Massachusetts Institute Of Technology | Compositions and methods for epithelial stem cell expansion and culture |
CN103405751B (zh) * | 2013-08-22 | 2015-05-20 | 赵轩 | 一种具有细胞修复功能的组合物及其制备方法和应用 |
US9636364B2 (en) | 2013-12-04 | 2017-05-02 | Stemnion, Inc. | Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve |
AU2015206236B2 (en) | 2014-01-17 | 2020-02-20 | Mimedx Group, Inc. | Method for inducing angiogenesis |
WO2015134951A1 (en) * | 2014-03-06 | 2015-09-11 | Amnio Technology Llc | Amnion derived therapeutic compositions and methods of use |
WO2015134936A1 (en) * | 2014-03-06 | 2015-09-11 | Amnio Technology Llc | Amnion derived therapeutic compositions and methods of use |
CN104977414B (zh) * | 2014-04-09 | 2016-09-28 | 上海交通大学医学院 | 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用 |
CN104014000A (zh) * | 2014-06-10 | 2014-09-03 | 白晋 | 一种应用于美容填充的注射试剂 |
KR102493376B1 (ko) | 2014-09-03 | 2023-01-27 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법 |
JP6964068B2 (ja) | 2015-04-03 | 2021-11-10 | プロパジェニクス インコーポレイテッド | 上皮細胞のエキソビボ増殖 |
WO2017004460A1 (en) * | 2015-06-30 | 2017-01-05 | Surgenex, LLC | Compositions and methods for flowable allograft tissue |
WO2017041027A1 (en) | 2015-09-04 | 2017-03-09 | Obi Pharma, Inc. | Glycan arrays and method of use |
EP3892717A1 (en) | 2015-09-11 | 2021-10-13 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
AU2017205194A1 (en) | 2016-01-08 | 2018-07-19 | Massachusetts Institute Of Technology | Production of differentiated enteroendocrine cells and insulin producing cells |
US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
KR20180121786A (ko) * | 2016-03-29 | 2018-11-08 | 오비아이 파머 인코퍼레이티드 | 항체, 제약 조성물 및 방법 |
CN105759056B (zh) * | 2016-04-06 | 2017-11-14 | 四川大学华西医院 | 一种肺癌筛查试剂盒 |
KR20230110820A (ko) | 2016-04-22 | 2023-07-25 | 오비아이 파머 인코퍼레이티드 | 글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에의한 암 면역요법 |
MA45502A (fr) | 2016-06-21 | 2019-04-24 | Janssen Biotech Inc | Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases |
CN110072545A (zh) | 2016-07-27 | 2019-07-30 | 台湾浩鼎生技股份有限公司 | 免疫原性/治疗性聚糖组合物及其用途 |
KR102528998B1 (ko) | 2016-07-29 | 2023-05-03 | 오비아이 파머 인코퍼레이티드 | 인간 항체, 제약 조성물 및 방법 |
KR102600091B1 (ko) * | 2016-08-24 | 2023-11-09 | (주)아모레퍼시픽 | 사이토칼라신 d를 포함하는 피부 미백용 조성물 |
JP2019535731A (ja) | 2016-11-21 | 2019-12-12 | オービーアイ ファーマ,インコーポレイテッド | コンジュゲートさせた生物学的分子、医薬組成物及び方法 |
SG10201910821XA (en) | 2016-12-30 | 2020-01-30 | Frequency Therapeutics Inc | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
WO2019099427A1 (en) * | 2017-11-14 | 2019-05-23 | The University Of North Carolina At Chapel Hill | Compositions and methods for stabilization of proteins |
KR20200103660A (ko) * | 2017-11-16 | 2020-09-02 | 에이비타 바이오메디컬, 인크. | 세포막 결합된 신호전달 인자의 용도 |
RU2673806C1 (ru) * | 2018-03-06 | 2018-11-30 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" | Способ оперативного лечения ожоговых ран |
JP6739472B2 (ja) * | 2018-05-30 | 2020-08-12 | 株式会社粧薬研究所 | ウマプラセンタエキスを有効成分とする剤 |
US11203645B2 (en) | 2018-06-27 | 2021-12-21 | Obi Pharma, Inc. | Glycosynthase variants for glycoprotein engineering and methods of use |
WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
CN113195707A (zh) | 2018-08-17 | 2021-07-30 | 频率治疗公司 | 用于通过上调jag-1来生成毛细胞的组合物和方法 |
CN113827618B (zh) * | 2021-10-20 | 2023-09-26 | 上海交通大学医学院附属仁济医院 | 干细胞条件培养基在制备用于治疗炎症性皮肤的药物中的用途 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5251009A (en) * | 1975-10-17 | 1977-04-23 | Morinaga Milk Ind Co Ltd | Method of producing drug for treating marrow leukemia |
US4391909A (en) | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
US4298002A (en) | 1979-09-10 | 1981-11-03 | National Patent Development Corporation | Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation |
US4361552A (en) | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
US4353888A (en) | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
GB2110531B (en) * | 1981-11-05 | 1985-05-01 | East Grinstead Research Trust | Wound healing composition prepared from amnion |
US4792525A (en) | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4879237A (en) | 1985-05-24 | 1989-11-07 | La Jolla Cancer Research Foundation | Use of peptides in control of cell attachment and detachment |
US4988621A (en) | 1985-05-24 | 1991-01-29 | La Jolla Cancer Research Foundation | Peptides in cell detachment and aggregation |
US4789734A (en) | 1985-08-06 | 1988-12-06 | La Jolla Cancer Research Foundation | Vitronectin specific cell receptor derived from mammalian mesenchymal tissue |
US5510254A (en) | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
US5106627A (en) | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
WO1991010470A1 (en) | 1990-01-08 | 1991-07-25 | Brown University Research Foundation | Devices and methods for enhanced delivery of active factors |
US5149543A (en) | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
DE69230142T2 (de) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Tech | Verfahren zur herstellung von spezifischen bindungspaargliedern |
US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
DE69317439T2 (de) | 1992-12-02 | 1998-07-02 | Shell Int Research | Azoxycyanbenzol-Derivate |
JP3720353B2 (ja) | 1992-12-04 | 2005-11-24 | メディカル リサーチ カウンシル | 多価および多重特異性の結合タンパク質、それらの製造および使用 |
US5496720A (en) | 1993-02-10 | 1996-03-05 | Susko-Parrish; Joan L. | Parthenogenic oocyte activation |
WO1995002698A1 (en) | 1993-07-12 | 1995-01-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
US6015671A (en) | 1995-06-07 | 2000-01-18 | Indiana University Foundation | Myocardial grafts and cellular compositions |
US5602301A (en) * | 1993-11-16 | 1997-02-11 | Indiana University Foundation | Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
JP4335310B2 (ja) | 1995-06-07 | 2009-09-30 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用 |
US5837234A (en) | 1995-06-07 | 1998-11-17 | Cytotherapeutics, Inc. | Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane |
JP3806189B2 (ja) * | 1995-07-27 | 2006-08-09 | 株式会社エスアールエル | ヒト羊膜細胞への遺伝子導入方法及び遺伝子治療用細胞の調製方法 |
US6117676A (en) * | 1995-07-27 | 2000-09-12 | Srl, Inc. | Transfected human amniotic cells and method for producing a gene product |
US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
US5705308A (en) | 1996-09-30 | 1998-01-06 | Eastman Kodak Company | Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element |
US6152142A (en) | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
CN1201697A (zh) * | 1997-06-07 | 1998-12-16 | 合肥市第一人民医院 | 人羊膜的制备方法 |
CA2296704C (en) | 1997-07-14 | 2010-10-19 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US5965997A (en) | 1997-08-20 | 1999-10-12 | Benchmarq Microelectronics | Battery monitoring circuit with storage of charge and discharge accumulation values accessible therefrom |
JP2000287680A (ja) * | 1999-04-09 | 2000-10-17 | Sentan Kagaku Gijutsu Incubation Center:Kk | 未成熟肝細胞を成熟肝細胞へ分化させる方法 |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
CA2377371A1 (en) * | 1999-06-22 | 2000-12-28 | David N. Herndon | Enhanced wound coverage to enhance wound healing |
US6428802B1 (en) | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
WO2001088103A2 (en) | 2000-05-12 | 2001-11-22 | University Of Utah Research Foundation | Compositions and methods for tissue dedifferentiation and regeneration |
US6534052B1 (en) | 2000-09-05 | 2003-03-18 | Yong-Fu Xiao | Cardiac function comprising implantation of embryonic stem cell in which differentiation has been initiated |
US6607720B1 (en) | 2000-09-05 | 2003-08-19 | Yong-Fu Xiao | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
JP4217037B2 (ja) * | 2001-08-10 | 2009-01-28 | 宣男 櫻川 | ヒト羊膜間葉細胞由来ヒト神経幹細胞 |
EP1288293A1 (en) * | 2001-08-30 | 2003-03-05 | Norio Sakuragawa | Human neural stem cells originated from human amniotic mesenchymal cell layer |
WO2003035697A1 (en) | 2001-09-27 | 2003-05-01 | Lg Household & Health Care Ltd. | Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same |
US20030082153A1 (en) * | 2001-10-22 | 2003-05-01 | The Government Of The United States Of America | Stem cells that transform to beating cardiomyocytes |
KR20050044393A (ko) * | 2001-11-09 | 2005-05-12 | 아르테셀 사이언스, 인크. | 지방 조직 유래된 스트로마 세포의 내분비 췌장 분화 및이의 용도 |
DE60233248D1 (de) | 2001-11-15 | 2009-09-17 | Childrens Medical Center | Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon |
TWI290055B (en) | 2002-03-14 | 2007-11-21 | Tissuetech Inc | Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes |
CN1205333C (zh) * | 2002-03-22 | 2005-06-08 | 雪原 | 羊膜组织工程支架羊膜完全脱细胞方法 |
AU2003231358A1 (en) * | 2002-04-17 | 2003-10-27 | Otsuka Pharmaceutical Co., Ltd. | METHOD OF FORMING PANCREATIC Beta CELLS FROM MESENCHYMAL CELLS |
US20040161419A1 (en) | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
JP2005523328A (ja) * | 2002-04-19 | 2005-08-04 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 胎盤由来の幹細胞及びその使用 |
US6909159B2 (en) | 2002-06-20 | 2005-06-21 | International Business Machines Corporation | Method and apparatus to make a semiconductor chip susceptible to radiation failure |
US20030235580A1 (en) * | 2002-06-24 | 2003-12-25 | Fen Zhang | Amniotic membrane mediated delivery of bioactive molecules |
EP1539930A4 (en) | 2002-07-29 | 2006-08-09 | Es Cell Int Pte Ltd | METHOD IN MULTIPLE STAGES OF DIFFERENTIATION OF POSITIVE INSULIN-SENSITIVE CELLS, GLUCOSE |
AU2003272536A1 (en) | 2002-09-18 | 2004-04-08 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
JP2004135578A (ja) * | 2002-10-17 | 2004-05-13 | Takashi Shioda | 肝幹細胞の増殖方法、肝細胞の増殖方法及び肝幹細胞 |
CN1506042A (zh) * | 2002-12-11 | 2004-06-23 | 苏加璐 | 使用来自胎儿细胞和组织的化合物改善皮肤状况的方法和组合物 |
CN1445363A (zh) * | 2003-01-17 | 2003-10-01 | 中山大学 | 体外诱导人胚胎干细胞定向分化为表皮干细胞的方法 |
JP4571387B2 (ja) * | 2003-02-07 | 2010-10-27 | 宣男 櫻川 | ヒト羊膜由来サイドポピュレーション細胞及びその用途 |
WO2004091288A2 (en) | 2003-04-09 | 2004-10-28 | Magee-Womens Health Corporation | Correcting mitotic spindle defects in somatic cell nuclear transfer |
CN100368534C (zh) * | 2003-05-01 | 2008-02-13 | 四川大学华西医院 | 生物衍生羊膜、复合生物衍生羊膜及其制备方法 |
CA2530533C (en) | 2003-06-27 | 2015-02-10 | Ethicon, Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
CN1228442C (zh) * | 2003-07-09 | 2005-11-23 | 暨南大学 | 胚胎干细胞定向诱导分化为肝细胞的方法 |
WO2005017117A2 (en) * | 2003-08-14 | 2005-02-24 | Martin Haas | Multipotent amniotic fetal stem cells (mafsc) and banking of same |
CA2536067A1 (en) * | 2003-08-27 | 2005-03-10 | Stemcells California, Inc. | Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations |
CA2448337A1 (en) | 2003-11-03 | 2005-05-03 | Bayer Inc. | Butyl-type rubber with high viscosity |
CN100564518C (zh) * | 2004-07-20 | 2009-12-02 | 成都军区昆明总医院 | 胎盘羊膜细胞提取物及其在间充质干细胞诱导分化中的应用 |
DK1789534T3 (en) * | 2004-08-16 | 2014-11-17 | Cellres Corp Pte Ltd | ISOLATION OF stem / progenitor cells FOSTER HINDE FROM an umbilical cord |
-
2006
- 2006-03-29 CN CN201310158562.4A patent/CN103361303B/zh active Active
- 2006-03-29 DK DK06748846.0T patent/DK1864132T3/da active
- 2006-03-29 ES ES06748846T patent/ES2387402T3/es active Active
- 2006-03-29 CN CN201310158551.6A patent/CN103356709B/zh not_active Expired - Fee Related
- 2006-03-29 CA CA2602684A patent/CA2602684C/en active Active
- 2006-03-29 EP EP06748846A patent/EP1864132B1/en active Active
- 2006-03-29 CN CN201310158548.4A patent/CN103356708B/zh active Active
- 2006-03-29 CN CN2013101579638A patent/CN103361301A/zh active Pending
- 2006-03-29 CN CN201310158534.2A patent/CN103356707B/zh active Active
- 2006-03-29 CN CN201310157915.9A patent/CN103356703B/zh not_active Expired - Fee Related
- 2006-03-29 CN CN200680019392XA patent/CN101589137B/zh active Active
- 2006-03-29 CN CN201310157917.8A patent/CN103356704B/zh active Active
- 2006-03-29 JP JP2008504278A patent/JP5017253B2/ja active Active
- 2006-03-29 CN CN2013101585446A patent/CN103361302A/zh active Pending
- 2006-03-29 WO PCT/US2006/011392 patent/WO2006105152A2/en active Application Filing
- 2006-03-29 CN CN201310157956.8A patent/CN103361300B/zh active Active
- 2006-03-29 CN CN201310158531.9A patent/CN103356706B/zh not_active Expired - Fee Related
- 2006-03-29 EP EP12154777A patent/EP2460875A1/en not_active Withdrawn
- 2006-03-29 CN CN201310157970.8A patent/CN103356705B/zh not_active Expired - Fee Related
-
2008
- 2008-04-03 HK HK08103796.2A patent/HK1109803A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1109803A1 (en) | Amnion-derived cell compositions, methods of making and uses thereof | |
HUS1800021I1 (hu) | Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások | |
HRP20190220T1 (hr) | Anti-il-23 protutijela, pripravci, postupci i upotrebe | |
EP2089510A4 (en) | STEM CELLS FROM THE AMNION AND USES THEREOF | |
IL231889A0 (en) | Preparations containing a dendritic cell and methods | |
EP1883389A4 (en) | LOW IRRITANT COMPOSITIONS AND METHODS OF MAKING SAME | |
EP1838846A4 (en) | METHODS AND COMPOSITIONS FOR ENCAPSULATING CELLS | |
HK1125395A1 (en) | Interpenetrating networks, and related methods and compositions | |
EP1895838A4 (en) | COMPOSITIONS AND METHODS | |
PL1928840T3 (pl) | 1H-pirazolo-4-karboksyamidy, ich wytwarzanie i ich zastosowanie jako inhibitory dehydrogenazy 11-beta-hydroksysteroidowej | |
HK1113689A1 (en) | Novel cellular compositions and methods for their preparation | |
EP1959960A4 (en) | Specific chemical properties, compositions and methods | |
IL211089A0 (en) | Compositions and methods for cell killing | |
ZA200707903B (en) | Colourant compositions and their use | |
EP1848438A4 (en) | DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE | |
EP1871914A4 (en) | METHOD AND COMPOSITIONS FOR INTRODUCING BIOPOLYMERS IN CELLS | |
EP1781337A4 (en) | METHODS AND COMPOSITIONS FOR CELL ACTIVATION | |
GB0501348D0 (en) | Compositions and methods | |
IL187217A0 (en) | Cell nucleus-entering compositions | |
GB0504185D0 (en) | Improved glazing composition and uses thereof | |
GB0525968D0 (en) | Compositions and methods | |
AU2005902195A0 (en) | Composition and uses thereof | |
GB0502889D0 (en) | Novel method and compositions |